Latest Onego Bio News & Updates

See the latest news and media coverage for Onego Bio. We track all announcements, press releases, and industry mentions in real time, all in one place.

Onego Bio

Food ingredient company producing animal-free egg protein

onego.bio

Headquarters: Helsinki, Finland
Founded year: 2022
Company type: Private company
Number of employees: 50–62
Industry: Food Processing

Last updated October 16

Latest news about Onego Bio

In short: Onego Bio sought a Jefferson County land-deal extension and lost its lawsuit against The EVERY Company.

Company announcements

October 16 Onego Bio

Onego Bio introduces Bioalbumen egg protein

The versatile ingredient aims to simplify food manufacturing by improving predictability and performance for manufacturers.

November 3, 2025 Onego Bio

Onego Bio receives FDA no-questions letter

The FDA confirms Bioalbumen® as GRAS for many food uses, enabling commercial use of precision-fermented egg protein identical to ovalbumin.

September 23, 2025 Onego Bio

Onego Bio receives FDA no-questions GRAS letter

FDA confirmed Bioalbumen® is GRAS for diverse food uses; the precision-fermented ovalbumin enables commercial use and supports planned U.S. manufacturing expansion.

April 2, 2024 Onego Bio

Onego Bio raises $40 million in Series A funding

The funding will scale commercialization and manufacturing of animal-free egg protein via precision fermentation with major investors involved.

Media coverage

October 7, 2025 Food Business News

FDA gives Onego Bio’s egg replacer the go-ahead

SAN DIEGO — The US Food and Drug Administration (FDA) has issued a “no questions” letter for Onego Bio’s Bioalbumen egg replacer, giving the company...

September 29, 2025 Milling Middle East & Africa

Onego Bio’s precision-fermented egg replacer clears key FDA hurdle

The FDA's “no questions” letter means the agency has reviewed Onego Bio's safety dossier and found no reason to challenge its conclusion...

September 22, 2025 Agence France-Presse

Onego Bio Receives FDA “No Questions” Letter on GRAS Status of Bioalbumen®

Onego Bio, a food ingredient company producing egg protein through precision fermentation, announced today that the U.S. Food and Drug Administration (FDA) has issued a...

September 21, 2025 The Globe and Mail

Agronomics Limited Announces Onego Bio Update

Onego Bio Receives FDA "No Questions" Letter on GRAS Status of Bioalbumen(R) DOUGLAS, ISLE OF MAN / ACCESS Newswire / September 23, 2025 / Onego...

Never miss news about Onego Bio

Track Onego Bio and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.